Chimerix (CMRX) Q1 2022 Earnings Call Transcript
One, to announce the sale of TEMBEXA to Emergent Biosolutions, and one, announcing our first quarter operating operations. Before we begin, I would like to remind you that the statements made on today's call include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and are subject to risks and uncertainties, and other factors.